Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New viral vaccines.

Ann M Arvin, Harry B Greenberg

    Virology
    |December 21, 2005
    PubMed
    Summary
    This summary is machine-generated.

    New viral vaccines offer significant advancements in preventing diseases caused by rotavirus, influenza, human papillomavirus, and varicella-zoster virus. These innovations translate basic research into clinical benefits for public health.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Human vaccine responses regulated by parallel cytokine pathways.

    Nature immunology·2026
    Same author

    Cryogenic electron tomography reveals herpesvirus capsid assembly intermediates inside the cell nucleus.

    Nature communications·2026
    Same author

    Mutations of two amino acids in VP5 mediate the attenuation of human rotavirus vaccine: evidence from <i>in vitro</i> and <i>in vivo</i> studies.

    Journal of virology·2025
    Same author

    Cryogenic Electron Tomography Redefines Herpesvirus Capsid Assembly Intermediates Inside the Cell Nucleus.

    bioRxiv : the preprint server for biology·2025
    Same author

    Breast milk delivery of an engineered dimeric IgA protects neonates against rotavirus.

    Mucosal immunology·2025
    Same author

    Viroporin activity is necessary for intercellular calcium signals that contribute to viral pathogenesis.

    Science advances·2025
    Same journal

    Unveiling the hidden virome of Sclerotinia sclerotiorum: New tools and discoveries in mycovirus detection.

    Virology·2026
    Same journal

    ASFV pDP238L negatively regulates type I interferon production via inhibiting the methylation of TBK1.

    Virology·2026
    Same journal

    Divergent poxvirus identified in a non-native black rat from Madagascar.

    Virology·2026
    Same journal

    Genomic and functional characterization of Bacillus phage BCE1 targeting a key gut bacterium in Aedes albopictus larvae.

    Virology·2026
    Same journal

    Viral etiology of orogenital papillomatosis and squamous cell carcinoma in bottlenose dolphins in the southeastern United States.

    Virology·2026
    Same journal

    Orthoflaviviruses in the modern era: Challenges and breakthroughs.

    Virology·2026
    See all related articles

    Area of Science:

    • Virology
    • Immunology
    • Vaccinology

    Background:

    • Vaccination is a cornerstone of public health, effectively preventing and controlling viral diseases.
    • Past successes include vaccines against smallpox, polio, measles, and hepatitis B, significantly reducing global disease burden.
    • Ongoing research in virology and immunology promises further progress in combating viral infections.

    Purpose of the Study:

    • To review four emerging viral vaccines representing the translation of basic research into clinical applications.
    • To highlight vaccines against rotavirus, influenza A and B, human papillomavirus, and varicella-zoster virus.
    • To examine the potential impact of these new vaccines on disease control in various populations.

    Main Methods:

    • Review of recent scientific literature and clinical trial data.

    Related Experiment Videos

  • Analysis of vaccine technologies, including live attenuated and subunit approaches.
  • Assessment of the clinical benefits and public health implications of new vaccine candidates.

    • Main Results:

    • Live attenuated vaccines against rotavirus and influenza (RNA viruses) are demonstrating efficacy.
    • Vaccines targeting human papillomavirus and varicella-zoster virus (DNA viruses) show promise in preventing persistent infections.
    • While only the influenza vaccine is currently licensed in the US, others are anticipated for introduction soon.

    Conclusions:

    • Recent advances in viral vaccine development offer powerful new tools for disease prevention.
    • These vaccines, targeting significant viral pathogens, are expected to have a profound impact on global health.
    • Continued basic research is crucial for addressing challenging viral targets like HIV, RSV, and HCV.